Theratechnologies Price/Sales
What is the Price/Sales of Theratechnologies?
The Price/Sales of Theratechnologies Inc. is 1.20
What is the definition of Price/Sales?
Price to sales ratio is a company’s stock price compared to its revenues.
ttm (trailing twelve months)
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales of companies in the Health Care sector on NASDAQ compared to Theratechnologies
What does Theratechnologies do?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Companies with price/sales similar to Theratechnologies
- Vulcan Steel Ltd has Price/Sales of 1.20
- Clifford Modern Living has Price/Sales of 1.20
- Bhageria Industries has Price/Sales of 1.20
- Hind Rectifiers has Price/Sales of 1.20
- Top Spring International has Price/Sales of 1.20
- Changsha Broad Homes Industrial Co has Price/Sales of 1.20
- Theratechnologies has Price/Sales of 1.20
- Qinqin Foodstuffs (Cayman) has Price/Sales of 1.20
- Acusphere has Price/Sales of 1.20
- TCPL Packaging has Price/Sales of 1.20
- Total Gabon has Price/Sales of 1.20
- USD Partners LP has Price/Sales of 1.20
- Wuhan Bester Telecom Co has Price/Sales of 1.20